Prof Ben Panizza is the Chairman of Otolaryngology - Head and Neck Surgery for Metro South and Director of the Queensland Head and Neck Cancer Centre. He has been active in head and neck cancer management for 25 years. He has created innovative approaches in dealing with malignancies extending to the skull base one of the most anatomically complex regions of the body. He is recognised as a world leader in cutaneous malignancy extending to the temporal bone and perineurial spread of keratinocyte skin cancers, being regularly invited overseas to present. Prof Panizza is active in integrating new treatments with surgery to change treatment paradigms and improve outcomes for patients. He is a professor in the Faculty of Medicine at the University of Queensland and works collaboratively with basic scientist and has supervised to completion 25 research higher degrees over the last 10 years. He has established an in department clinical trials unit to run clinical trials from proof of principle to phase 3 clinical trials enabling access and rapid translation for his scientific partners at the Princess Alexandra Hospital which has one of Australia's largest head and neck clinics. Prof Panizza is a clinical consultant and advisor to industry (Merck, Sanofi, QBiotics, Decibel Therapeutics) and sits on the governing bodies of both the International Federation of Head and Neck Oncological Societies and The World Federation of Skull Base Societies. He is active in publishing and sits on the editorial boards of the major head and neck journals (Head Neck, Oral Oncology, Skull Base, ANZ Journal of Surgery).